Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients (Q42978510)

From Wikidata
Jump to navigation Jump to search
scientific article published on 29 April 2008
edit
Language Label Description Also known as
English
Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients
scientific article published on 29 April 2008

    Statements

    Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients (English)
    Eric Lawitz
    Maribel Rodriguez-Torres
    Andrew J Muir
    Tara L Kieffer
    Ariya Khunvichai
    John G McHutchison
    29 April 2008
    163-169

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit